PEX5 and Zellweger spectrum disorders: Peroxisome turnover is controlled by the peroxisome mean lifetime τ. We recently demonstrated that this model is applicable to a range of experimental and disease conditions, e.g. loss of PEX5 in Zellweger spectrum disorders [21].